Andarix Pharmaceuticals   Report issue

For profit Phase 1
Founded: Somerville MA United States (2017)
Status: Left NME R&D (2004)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

rhenium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Small Cell (Phase 1)

Lung Neoplasms (Phase 1)

Neoplasm Recurrence, Local (Phase 1)

Neoplasms (Phase 1)

Recurrence (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1